Literature DB >> 33621603

Zebrafish (Danio rerio) larvae show behavioral and embryonic development defects when exposed to opioids at embryo stage.

Marilia R Sales Cadena1, Pabyton G Cadena2, Meredith R Watson3, Swapnalee Sarmah4, Stephen L Boehm Ii3, James A Marrs5.   

Abstract

Opioid abuse continues to plague society, and in recent years, there has been an epidemic, leading to increased addiction and death. It is poorly understood how prenatal opioid use affects the lives of children. The aim of this work was to evaluate the effect of early embryonic codeine or morphine exposure in zebrafish (Danio rerio), examining gastrulation progression (epiboly), teratogenic effects, mortality and locomotor behavior response to light/dark cycles. Zebrafish embryos were exposed to codeine or morphine (designated C or M) at 1, 5 or 10 mg/L (designated 01, 05 or 10, respectively) from 3 to 24 h postfertilization (hpf) or from 3 to 48 hpf (designated -24 or - 48 for 1 or 2 days of exposure, respectively). The C10-24, C01-48, C05-48 and C10-48 groups showed significantly smaller eyes than control larvae at 7 days postfertilization (dpf). Locomotor behavior of control larvae in light/dark cycles showed greater swimming time and distance in dark cycles. Two-day codeine exposure produced strong effects, showing no significant response due to light/dark cycles in distance moved. Morphine exposed groups showed similar effects as observed in 2-day codeine exposed groups, showing less large movement activity and also no significant difference between inactive duration in response to light/dark cycles. In conclusion, we observed low teratogenic effects and mortality effects. Animals exposed to high levels and higher exposure times of opioids were hypoactive, relative to controls, in the dark period. Future studies will be needed to understand the neural defects producing behavior changes.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Codeine; Eye defect; Locomotor behavior; Morphine; Swimming activity; Zebrafish embryotoxicity

Mesh:

Substances:

Year:  2021        PMID: 33621603      PMCID: PMC8137531          DOI: 10.1016/j.ntt.2021.106964

Source DB:  PubMed          Journal:  Neurotoxicol Teratol        ISSN: 0892-0362            Impact factor:   3.763


  29 in total

Review 1.  The Use of Larval Zebrafish (Danio rerio) Model for Identifying New Anxiolytic Drugs from Herbal Medicine.

Authors:  Yuvendran Muniandy
Journal:  Zebrafish       Date:  2018-05-31       Impact factor: 1.985

Review 2.  Zebrafish models to study drug abuse-related phenotypes.

Authors:  Adam Stewart; Keith Wong; Jonathan Cachat; Siddharth Gaikwad; Evan Kyzar; Nadine Wu; Peter Hart; Valerie Piet; Eli Utterback; Marco Elegante; David Tien; Allan V Kalueff
Journal:  Rev Neurosci       Date:  2011       Impact factor: 4.353

Review 3.  Common congenital anomalies: Environmental causes and prevention with folic acid containing multivitamins.

Authors:  Swapnalee Sarmah; Pooja Muralidharan; James A Marrs
Journal:  Birth Defects Res C Embryo Today       Date:  2016-10-07

4.  Modeling withdrawal syndrome in zebrafish.

Authors:  Jonathan Cachat; Peter Canavello; Marco Elegante; Brett Bartels; Peter Hart; Carisa Bergner; Rupert Egan; Ashley Duncan; David Tien; Amanda Chung; Keith Wong; Jason Goodspeed; Julia Tan; Chelsea Grimes; Salem Elkhayat; Christopher Suciu; Michael Rosenberg; Kyung Min Chung; Ferdous Kadri; Sudipta Roy; Siddharth Gaikwad; Adam Stewart; Ivan Zapolsky; Thomas Gilder; Sopan Mohnot; Esther Beeson; Hakima Amri; Zofia Zukowska; R Denis Soignier; Allan V Kalueff
Journal:  Behav Brain Res       Date:  2009-12-16       Impact factor: 3.332

5.  Exposure to dilute concentrations of bupropion affects zebrafish early life stages.

Authors:  Mariana Bernardes Franco; Thayres S Andrade; Diego Sousa-Moura; Muriel Lopes da Silva; Irvin Bryan Machado Ferraz; Níchollas Serafim Camargo; Inês Domingues; Rhaul Oliveira; Cesar Koppe Grisolia
Journal:  Chemosphere       Date:  2019-01-25       Impact factor: 7.086

6.  Driving under the influence of opiates: concentration relationships between morphine, codeine, 6-acetyl morphine, and ethyl morphine in blood.

Authors:  A Wayne Jones; Anita Holmgren; Fredrik C Kugelberg
Journal:  J Anal Toxicol       Date:  2008-05       Impact factor: 3.367

Review 7.  Zebrafish models relevant to studying central opioid and endocannabinoid systems.

Authors:  Konstantin A Demin; Darya A Meshalkina; Elana V Kysil; Kristina A Antonova; Andrey D Volgin; Oleg A Yakovlev; Polina A Alekseeva; Maria M Firuleva; Anton M Lakstygal; Murilo S de Abreu; Leonardo J G Barcellos; Wandong Bao; Ashton J Friend; Tamara G Amstislavskaya; Denis B Rosemberg; Pavel E Musienko; Cai Song; Allan V Kalueff
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2018-03-28       Impact factor: 5.067

Review 8.  Animal models of human disease: zebrafish swim into view.

Authors:  Graham J Lieschke; Peter D Currie
Journal:  Nat Rev Genet       Date:  2007-05       Impact factor: 53.242

9.  Mitragynine attenuates withdrawal syndrome in morphine-withdrawn zebrafish.

Authors:  Beng-Siang Khor; Mohd Fadzly Amar Jamil; Mohamad Ilham Adenan; Alexander Chong Shu-Chien
Journal:  PLoS One       Date:  2011-12-21       Impact factor: 3.240

10.  Influence of kinship and MHC class II genotype on visual traits in zebrafish larvae (Danio rerio).

Authors:  Cornelia Hinz; Katharina Gebhardt; Alexander K Hartmann; Lauren Sigman; Gabriele Gerlach
Journal:  PLoS One       Date:  2012-12-10       Impact factor: 3.240

View more
  1 in total

1.  Analysis of the Expression of Neurotrophins and Their Receptors in Adult Zebrafish Kidney.

Authors:  Pietro Cacialli; Carla Lucini
Journal:  Vet Sci       Date:  2022-06-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.